Oregon Public Employees Retirement Fund’s Sarepta Therapeutics SRPT Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Buy	24,036 +100	+0.4%	+$1.89K	﹤0.01%	1284
2026 Q1	$521K	Sell	23,936 -64	-0.3%	-$1.24K	0.01%	1158
2025 Q4	$516K	Buy	24,000 +2,000	+9%	+$42.1K	0.01%	1139
2025 Q3	$424K	Buy	22,000 +1,855	+9%	+$33.1K	0.01%	1198
2025 Q2	$344K	Buy	20,145 +800	+4%	+$34.1K	0.01%	1246
2025 Q1	$1.23M	Sell	19,345 -100	-0.5%	-$10.5K	0.02%	646
2024 Q4	$2.36M	Hold	19,445	–	–	0.04%	357
2024 Q3	$2.43M	Sell	19,445 -155	-0.8%	-$21.4K	0.05%	346
2024 Q2	$3.1M	Buy	+19,600	New	+$2.52M	0.06%	250
2020 Q4	–	Sell	-7,552	Closed	-$1.06M	–	1614
2020 Q3	$1.06M	Sell	7,552 -500	-6%	-$76K	0.02%	744
2020 Q2	$1.29M	Sell	8,052 -5,148	-39%	-$701K	0.02%	659
2020 Q1	$1.29M	Buy	+13,200	New	+$1.51M	0.02%	599

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Oregon Public Employees Retirement Fund's SRPT Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Sarepta Therapeutics (SRPT) stake by 0.42% in Q2 2026, buying an estimated $1.89K and bringing the position to 24,036 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

Oregon Public Employees Retirement Fund first reported a position in SRPT in Q1 2020 and has held it in 12 quarters since. The position peaked at $3.1M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Oregon Public Employees Retirement Fund held 24,036 shares of Sarepta Therapeutics worth $432K as of Q2 2026.
Oregon Public Employees Retirement Fund bought 100 Sarepta Therapeutics shares in Q2 2026, an estimated $1.89K.
Sarepta Therapeutics made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1284 holding.
Oregon Public Employees Retirement Fund first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 12 quarters since.
Oregon Public Employees Retirement Fund's Sarepta Therapeutics position peaked at $3.1M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.